$4.53
0.22% yesterday
Nasdaq, Jun 11, 10:17 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$4.53
+0.18 4.14% 1M
-0.33 6.79% 6M
-0.12 2.58% YTD
-4.36 49.04% 1Y
-28.47 86.27% 5Y
-28.47 86.27% 10Y
-28.47 86.27% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
-0.01 0.22%
ISIN
US38246G1085
Symbol
GDRX

Key metrics

Market capitalization $1.62b
Enterprise Value $1.81b
P/E (TTM) P/E ratio 56.63
EV/FCF (TTM) EV/FCF 22.77
EV/Sales (TTM) EV/Sales 2.27
P/S ratio (TTM) P/S ratio 2.03
P/B ratio (TTM) P/B ratio 2.50
Revenue growth (TTM) Revenue growth 4.34%
Revenue (TTM) Revenue $797.41m
EBIT (operating result TTM) EBIT $77.00m
Free Cash Flow (TTM) Free Cash Flow $79.41m
Cash position $300.98m
EPS (TTM) EPS $0.08
P/E forward 29.31
P/S forward 1.97
EV/Sales forward 2.20
Short interest 4.77%
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a GoodRx Holdings forecast:

9x Buy
50%
8x Hold
44%
1x Sell
6%

Analyst Opinions

18 Analysts have issued a GoodRx Holdings forecast:

Buy
50%
Hold
44%
Sell
6%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
797 797
4% 4%
100%
- Direct Costs 49 49
21% 21%
6%
748 748
7% 7%
94%
- Selling and Administrative Expenses 467 467
5% 5%
59%
- Research and Development Expense 124 124
8% 8%
16%
152 152
94% 94%
19%
- Depreciation and Amortization 75 75
31% 31%
9%
EBIT (Operating Income) EBIT 77 77
352% 352%
10%
Net Profit 28 28
532% 532%
4%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
Business Wire
2 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription service for erectile dysfunction (ED). Designed to meet consumers where they are and remove common barriers such as high costs, long wait times, and inconvenience, this all-in-one solution offers a fast, discreet, and affordable ...
Neutral
Business Wire
3 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of GoodRx Community Link. Designed to address the industry challenges that independent community pharmacies face around complex reimbursement models and competitive pressures, Community Link leverages a cost-plus pricing model based on NADAC to provid...
Positive
Seeking Alpha
6 days ago
I'm reiterating my Buy rating on GoodRx, as its valuation is compelling and the business is showing signs of stabilization under new leadership. GoodRx's recurring revenue base, expanding pharma partnerships, and robust EBITDA margins support the investment thesis for a rebound. Despite risks like Rite Aid's bankruptcy and flat consumer growth, GoodRx's direct pharma channel is growing double d...
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website investors.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today